Latanoprost Comp Ratiopharm (Timolol Maleate, Latanoprost)

Timolol maleate is a non‑selective beta‑adrenergic blocker. By blocking beta receptors in the ciliary body, it reduces the production of aqueous humor, which contributes to a decrease in intra‑ocular pressure.

The dosing regimen for Latanoprost Comp Ratiopharm is determined by the prescribing ophthalmologist based on the individual patient's condition, response, and tolerance. Patients should follow the prescriber’s instructions exactly.

Safety data for use during pregnancy or lactation are limited. The product should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The combination provides dual mechanisms—timolol reduces aqueous humor production while latanoprost enhances outflow—offering greater intra‑ocular pressure reduction than either agent alone. This can simplify therapy by using a single bottle instead of two separate eye drops.

Store the eye‑drop bottles at room temperature, preferably below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and discard any product that appears discolored or cloudy.

The medication is applied as one drop into the affected eye(s) once daily, usually in the evening, unless otherwise directed by the prescriber. Patients should avoid touching the tip of the bottle to the eye or any other surface.

Serious risks include severe allergic reactions, marked reduction in heart rate or blood pressure, bronchospasm in patients with asthma or COPD, and worsening of glaucoma if the drug is not tolerated. Any of these symptoms require immediate medical attention.

Patients with known hypersensitivity to timolol, latanoprost, or any excipients in the formulation should avoid this product. It is also contraindicated in individuals with severe sinusitis, active ocular infections, or those who cannot tolerate beta‑blockers due to cardiac or respiratory conditions.